Healthcare technology company Symplr, backed by Clearlake Capital, is in the midst of a single-asset secondaries deal, PE Hub reports. The secondaries process comes after Symplr returned to market earlier this year with Evercore, Goldman Sachs and William Blair exploring transactions including a stake sale, as PE Hub reported in June. Charlesbank made a minority investment in Symplr in a deal that valued the company in the range of $3.3 billion to $3.5 billion. Read more.
Related Posts
Fundraiser Nets $114K for St. Jude Children’s Research Hospital®
St. Jude is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
March 18, 2022
CareAlign Raises $2.3M
The company offers a task management system for healthcare providers.
December 2, 2021
With $22.3M in Venture Capital, a Startup is Transforming Maternity Care
Oula raised the seed and Series A rounds to improve outcomes for pregnant and postpartum individuals.
February 9, 2023
BabyLiveAdvice™ Raises $1.1M Seed Round to Improve Maternal-Infant TeleHealth
Venn Ventures and Synergen Technology Labs led the round. Investors also included Ob Hospitalist Group, CareFirst BCBS, and hospital system LifeBridge Health.
September 13, 2022